© 2022 MJH Life Sciences and Urology Times. All rights reserved.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
A panel of urology experts discuss advances in prostate cancer imaging and how it informs providers and influences patient care decision-making while reviewing several patient profiles.
March 23rd 2022
A background on the available options and recent advances in prostate cancer imaging.
The panel explains the science behind PSMA PET scans and reviews the different positron-emitters used in the scans.
March 31st 2022
Experts review ongoing clinical trials in PSMA PET technology.
April 1st 2022
An explanation of the importance of clinical providers following a multidisciplinary approach for prostate cancer management.
April 8th 2022
Michael Gorin, MD, describes his experiences with prostate cancer imaging both in academia and community-based practices.
Doctors present the patient profile of a 66-year-old man with high-risk localized prostate cancer.
April 19th 2022
Key opinion leaders review the OSPREY clinical trial studying PSMA PET scans for prostate cancer imaging.
Authors from the OSPREY clinical trial highlight the key take-home messages from the trial outcomes.
April 20th 2022
Dr Lawrence Saperstein describes the importance of coronal images and visual analysis in making a thoughtful treatment plan for prostate cancer.
A radiation oncologist explains how to discuss the interpretation of prostate cancer imaging with patients in deciding on a treatment plan.